These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Antibodies to GAD in Japanese diabetic patients: a multicenter study. Tsuruoka A; Matsuba I; Toyota T; Isshiki G; Nagataki S; Ikeda Y Diabetes Res Clin Pract; 1995 Jun; 28(3):191-9. PubMed ID: 8529498 [TBL] [Abstract][Full Text] [Related]
9. GAD antibodies in IDDM in Thailand. Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876 [No Abstract] [Full Text] [Related]
10. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321 [TBL] [Abstract][Full Text] [Related]
11. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Taniguchi T; Okazaki K; Okamoto M; Seko S; Uchida K; Seino Y Diabetes Care; 2001 Sep; 24(9):1695-6. PubMed ID: 11522728 [No Abstract] [Full Text] [Related]
12. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy. Zanone MM; Petersen JS; Peakman M; Mathias CJ; Watkins PJ; Dyrberg T; Vergani D Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies. Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889 [TBL] [Abstract][Full Text] [Related]
14. GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency. Hatziagelaki E; Jaeger C; Maeser E; Bretzel RG; Federlin K Acta Diabetol; 1996 Dec; 33(4):291-4. PubMed ID: 9033970 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to GAD in elderly patients with previously diagnosed NIDDM. Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369 [No Abstract] [Full Text] [Related]
16. Relationship between GAD antibody and residual beta-cell function in children after overt onset of IDDM. Yokota I; Shirakawa N; Shima K; Matsuda J; Naito E; Ito M; Kuroda Y Diabetes Care; 1996 Jan; 19(1):74-5. PubMed ID: 8720540 [No Abstract] [Full Text] [Related]
17. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950 [TBL] [Abstract][Full Text] [Related]
18. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530 [TBL] [Abstract][Full Text] [Related]
19. Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review. Kobayashi M; Ohara N; Ikeda Y; Nagano O; Takada T; Kodama M; Sone H Intern Med; 2018 Dec; 57(24):3581-3587. PubMed ID: 30101912 [TBL] [Abstract][Full Text] [Related]
20. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy. Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590 [No Abstract] [Full Text] [Related] [Next] [New Search]